(Q71989529)

English

ErbB-2 oncoprotein overexpression in breast carcinoma: Inverse correlation with biochemically- and immunohistochemically-determined hormone receptors

scientific article published on 01 August 1995

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647342%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

ErbB-2 oncoprotein overexpression in breast carcinoma: inverse correlation with biochemically- and immunohistochemically-determined hormone receptors (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647342%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

ErbB-2 oncoprotein overexpression in breast carcinoma: Inverse correlation with biochemically- and immunohistochemically-determined hormone receptors (English)

1 reference

10.1007/BF00668210

https://api.crossref.org/works/10.1007/BF00668210

13 July 2024

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

A. A. Keshgegian

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7647342

13 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7647342

13 July 2024

publication date

1 August 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647342%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF00668210.pdf

Portable Document Format

1 reference

10.1007/BF00668210

https://api.crossref.org/works/10.1007/BF00668210

13 July 2024

http://link.springer.com/article/10.1007/BF00668210/fulltext.html

1 reference

10.1007/BF00668210

https://api.crossref.org/works/10.1007/BF00668210

13 July 2024

http://link.springer.com/content/pdf/10.1007/BF00668210

1 reference

10.1007/BF00668210

https://api.crossref.org/works/10.1007/BF00668210

13 July 2024

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647342%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647342%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647342%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

201-210

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647342%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Proto-oncogene amplification and human breast tumor phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer: retrospective follow-up study of 245 stage I and II cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological correlation between HER-2/neu and proliferative activity in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 expression in different histological types of invasive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Follow-up study of HER-2/neu amplification in primary breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of c-erbB-2 protein expression with histologic grade, lymph node involvement and steroid receptor status in human breast tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of c-erbB-2 activation in paraffin-embedded tissue by immunohistochemistry

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 andras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu amplification predicts poor survival in node-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long term prognostic significance of c-erbB-2 in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of her-2/neu oncogene in breast-cancer - correlation of quantitative immunocytochemistry and prognostic factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-ERBB-2 oncogens protein inIn situ and invasive lobular breast neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 amplification does not correlate with recurrence of disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 and c-erbA-1 (ear-1) gene amplification and c-erbB-2 protein expression in Japanese breast cancers: their relationship to the histology and other disease parameters.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 amplification in node-negative human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB2 expression in correlation to other biological parameters of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-erbB-2 Oncogene Product Expression Depends on Tumour Type and is Related to Oestrogen Receptor and Lymph Node Status in Human Breast Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERBB2 amplification in breast cancer with a high rate of proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7647342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00668210

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647342%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7647342%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71989529&oldid=2219550350"